Lab21 Ltd, a diagnostic service provider, has announced the acquisition of Myconostica Ltd of the UK which develops molecular tests for the diagnosis of fungal infections. Financial terms weren’t disclosed. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
